Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Chronic Lymphocytic Leukemia

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Chronic Lymphocytic Leukemia

Pagel Provides Perspective on Evolving Paradigms in CLL, DLBCL

John M. Pagel, MD, PhD, provides insight on the evolving treatment paradigms in CLL and DLBCL.

Read More >>

Time-Limited Triplet Emerges as a Potential Standard in Relapsed/Refractory CLL

Umbralisib Plus Ublituximab Improves PFS in Frontline and Relapsed/Refractory CLL

FDA Approves Ibrutinib/Rituximab for Frontline CLL/SLL

Mato Highlights Promise of Investigational Immunotherapeutics in CLL

Questions With BTK Inhibitors and Anti-CD20 Combos Require Further Study in CLL

View More Stories >>

View Conference Coverage

2020 ESMO Breast Cancer Virtual Meeting

2020 ASCO Virtual Scientific Program

2020 International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

2020 AACR Annual Meeting

2020 SGO Annual Meeting

Dr. Raphael on the Clinical Implications of the CLL14 Trial

Dr. Choi on Emerging Treatments in CLL

Dr. Barr on Novel Combination Strategies in CLL

Dr. Pagel on Ongoing Research With BTK Inhibitors in CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

2019 ASH; Best Abstracts for CLL

$CAR T-Cell Therapy for Relapsed/Refractory CLL$

CAR T-Cell Therapy for Relapsed/Refractory CLL

Sequencing Strategies for CLL

$PI3 Kinase Inhibitors for Relapsed/Refractory CLL$

Management of CLL Progression After Ibrutinib

OncLive houses thousands of videos that provide updates and information.
See more Videos

BTK Inhibitors in Chronic Lymphocytic Leukemia

Genomic Profiling in Chronic Lymphocytic Leukemia

Venetoclax-Based Regimens as First-Line Therapy in CLL

$Relapsed/Refractory CLL: Evaluating Other Novel Agents$

$Novel Approaches to Treating Relapsed/Refractory CLL$

$Continuing Therapy in Relapsed/Refractory CLL$

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Other Promising Strategies in CLL

This expert panel discussion led by William Wierda, MD, focuses on promising strategies available for the treatment of chronic lymphocytic leukemia. Dr. Wierda is joined in this discussion by Steven Coutre, MD; Matthew S. Davids, MD, MMSc; Nicole Lamanna, MD; and Shuo Ma, MD, PhD.